Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mirnext logo — Pioneering the future of cardiovascular health with innovati...

Mirnext

Pioneering the future of cardiovascular health with innovative miRNA biomarkers to enhance diagnosis and clinical management of heart-related conditions.

Founded 2012 Series Unknown Biotechnology, Health Care +3

General Information

Company Name Mirnext
Founded Year 2012
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series Unknown
Social

Get notified when Mirnext moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mirnext

Mirnext is a pioneering biomedical company founded in 2012 that focuses on revolutionizing the future of cardiovascular health. Through the identification, validation, and commercialization of miRNAs, Mirnext aims to introduce innovative biomarkers for cardiovascular disease. These circulating miRNAs play a crucial role as indicators for diagnosing heart failure, coronary artery disease, and myocardial infarction, as well as predicting cardiovascular risks such as mortality and hospitalization. In addition to this groundbreaking approach, Mirnext also creates multi-marker tests designed to enhance diagnostic procedures and clinical management for patients with heart-related conditions. The company is headquartered in Amsterdam, Netherlands. In a significant move, Mirnext secured its Venture Round investment on 01 January 2012 with the backing of Limburg Startup. Mirnext's dedication to addressing critical needs in cardiovascular health and its innovative use of miRNA biomarkers positions it as a promising player in the Biotechnology, Health Care, and Pharmaceutical industries.

Taxonomy: biomedical company, miRNA biomarkers, cardiovascular health, diagnostic procedures, clinical management, heart failure, coronary artery disease, myocardial infarction, predictive markers, multi-marker tests, Amsterdam, Netherlands

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jan 2012

Mirnext Alternatives & Competitors

Mirnext vs
Morris Heart Assoc
Morris Heart Assoc

Providing exceptional care for a range of heart and vascular conditions and symptoms, from atrial fi...

12 employees
Health Care
Mirnext vs
CardioDx
CardioDx

Empowering personalized cardiovascular care through advanced genomic diagnostics.

Series Unknown
Biotechnology, Health Care
Mirnext vs
VHS Arizona Heart Institute, Inc.
VHS Arizona Heart Institute, Inc.

Arizona Heart Institute World Class Cardiovascular Care in the Heart of Arizona Abrazo Arizona Heart...

1 employees
Education, Health Care

FAQ About Mirnext

Pioneering the future of cardiovascular health with innovative miRNA biomarkers to enhance diagnosis and clinical management of heart-related conditions.
Mirnext was founded in 2012.
Mirnext operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical, Lifestyle.
Mirnext has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Mirnext include Morris Heart Assoc, CardioDx, VHS Arizona Heart Institute, Inc., Alfieri Cardiology, AngioSafe, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mirnext and Morris Heart Assoc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mirnext and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy